17.75
-0.13 (-0.73%)
| Previous Close | 17.88 |
| Open | 17.73 |
| Volume | 3,313 |
| Avg. Volume (3M) | 8,990 |
| Market Cap | 227,469,792 |
| Price / Earnings (TTM) | 14.67 |
| Price / Sales | 4.66 |
| Price / Book | 0.820 |
| 52 Weeks Range | |
| Earnings Date | 8 Aug 2023 - 14 Aug 2023 |
| Profit Margin | 50.30% |
| Operating Margin (TTM) | 66.68% |
| Diluted EPS (TTM) | 1.41 |
| Quarterly Revenue Growth (YOY) | 153.10% |
| Quarterly Earnings Growth (YOY) | 869.90% |
| Total Debt/Equity (MRQ) | 11.00% |
| Current Ratio (MRQ) | 45.85 |
| Operating Cash Flow (TTM) | 26.90 M |
| Return on Assets (TTM) | 5.37% |
| Return on Equity (TTM) | 6.13% |
Market Trend
| Short Term | Medium Term | ||
| Industry | Asset Management (US) | Mixed | Mixed |
| Asset Management (Global) | Mixed | Mixed | |
| Stock | SWK Holdings Corporation | Mixed | Mixed |
AIStockmoo Score
| Analyst Consensus | NA |
| Insider Activity | NA |
| Price Volatility | -3.5 |
| Technical Moving Averages | 0.0 |
| Technical Oscillators | 0.0 |
| Average | 0.06 |
|
SWK Holdings Corp is a healthcare capital provider. The company offers financing solutions to various life science companies, institutions, and inventors. It involves monetizing cash flow streams derived from commercial-stage products and related intellectual property through royalty purchases and financings, as well as through the creation of synthetic revenue interests in commercialized products. Through its wholly-owned subsidiary, it also provides non-discretionary investment advisory services to institutional clients. The company's operating segments are Finance Receivables and Pharmaceutical Development Services. It generates maximum revenue from the Finance Receivables segment. |
|
| Sector | Financial Services |
| Industry | Asset Management |
| Investment Style | Small Value |
| % Held by Insiders | 6.38% |
| % Held by Institutions | 87.34% |
No data within this time range.
No data within this time range.
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
| Realized Profit | - |
| Unrealized Profit | - |
| Dividend Received 2026 | - |
| Total Profit | - |
| Avg. Return | - |
| Quantity (Buy) | - |
| Avg. Price (Buy) | - |
| Quantity (Sold) | - |
| Avg. Price (Sold) | - |